# Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)

> **NCT02799589** · PHASE4 · WITHDRAWN · sponsor: **Mofya Diallo**

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Dexmedetomidine
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT02799589
- **Lead sponsor:** Mofya Diallo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-07
- **Primary completion:** 2017-08
- **Final completion:** 2017-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulty in recruitment
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799589, "Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02799589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*